Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective is to evaluate the FreeO2 device combined with noninvasive respiratory support technique for COPD patients and postoperative bariatric surgery patients.
The main hypothesis is that FreeO2 device for oxygen therapy associated with NIV or nasal high flow oxygen therapy (NHFOT) allows to reach better oxygenation and avoid hypoxemia and hyperoxia.
Bariatric surgery patients:
The main objective of this study is to evaluate the time spent in the SpO2 target (+/- 2% SpO2 target) and partial pressure of carbon dioxide (PCO2) values on patients with morbid obesity after bariatric surgery.
COPD patients:
The main objective of this study is to evaluate the time spent in the SpO2 target (+/- 2% SpO2 target) and PCO2 values on patients with exacerbation of COPD (hypercapnic patients) with different ventilatory supports (NIV and NHFOT) associated with FreeO2.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COPD patients | Other | Patients with acute exacerbation of COPD and respiratory acidosis under oxygen therapy. |
|
| Bariatric surgery patients | Other | Obese patients after gastric surgery under CPAP. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Washout period | Other | During this period the patients will breath spontaneously oxygen titrated using the FreeO2 device with a SpO2 target set at 90%. The period duration is 30 minutes. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of time within SpO2 target | (SpO2 90 +/- 2%) | AECOPD Patients: Day 1; Up to 120 minutes after start study procedures. Bariatric surgery patients: Day 1; up to 75 minutes after start study procedures(post-op). |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of time in hypoxemia | (SpO2 < -2% of SpO2 target) | AECOPD Patients: Day 1; Up to 120 minutes after start study procedures. Bariatric surgery patients: Day 1; up to 75 minutes after start study procedures(post-op). |
| Percentage of time in severe hypoxemia |
Not provided
Inclusion Criteria (AECOPD):
Inclusion Criteria (Bariatric surgery post-op):
Exclusion Criteria:
Age < 18
Pregnancy
Respiratory distress or other clinical situation requiring continuous NIV or CPAP
Glasgow < 12 or agitation/delirium/dementia (limiting NIV)
Any contraindication to NIV (state requiring immediate endotracheal intubation, pneumothorax, recent esophagus surgery)
Hemodynamic instability (at the beginning of the study) (increasing doses of vasopressors or inotropes)
Refusal to consent to the study
5 patient with AECOPD and 5 patient with bariatric surgery will be included.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| François Lellouche, MD, PhD | Contact | 418-656-8711 | 3572 | Francois.Lellouche@criucpq.ulaval.ca |
| Miguel Trottier, MD, CM | Contact | miguel.trottier.1@ulaval.ca |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut universitaire de Cardiologie et de Pneumologie - Université Laval | Recruiting | Québec | Quebec | G1V 4G5 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| NIV - FreeO2 | Device | During this period the patients will receive NIV using FreeO2 device for oxygen titration with a SpO2 target set at 90%. Initially, the inspiratory pressure will be set to obtain a tidal volume between 6 to 8 mL/Kg of predictive body weight and positive end-expiratory end pressure (PEEP) at 5 centimeters of water (cmH2O). After NIV initiation, the parameters can be adjusted to improve patient comfort. The period duration is 30 minutes. |
|
| Nasal High flow Oxygen therapy - FreeO2 | Device | During this period the patients will receive NHFOT using the FreeO2 device for oxygen titration with a SpO2 target set at 90%. The high flow device will be set at 30 lpm.The period duration is 30 minutes. |
|
| CPAP - Oxygen constant flow | Other | During this period, the patients will have their own CPAP with oxygen adjusted by hospital staff according to hospital protocol. The period duration is 15 minutes. |
|
| CPAP - FreeO2 | Other | During this period, the patients will have their own CPAP with oxygen adjusted using the FreeO2 device. SpO2 target will be set at 90% The period duration is 60 minutes. |
|
(SpO2 < -5% of SpO2 target) |
| AECOPD Patients: Day 1; Up to 120 minutes after start study procedures. Bariatric surgery patients: Day 1; up to 75 minutes after start study procedures(post-op). |
| Percentage of time in hyperoxia | (> +5% of SpO2 target) | AECOPD Patients: Day 1; Up to 120 minutes after start study procedures. Bariatric surgery patients: Day 1; up to 75 minutes after start study procedures(post-op). |
| PCO2 value after each period | Measure PCO2 with blood gases after each period | AECOPD Patients: Day 1; 30 minutes, 60 minutes, 90 minutes, 120 minutes after start study procedures. Bariatric surgery patient: Day 1; 15 minutes and 75 minutes after start study procedures. |
| ID | Term |
|---|---|
| D056128 | Obesity, Abdominal |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided